In 2021, the global parenteral nutrition market size was valued at around US$ 6.38 Bn and expected to reach US$ 9.82 billion by 2030 with a CAGR of 4.9% from 2022 to 2030.
The rising incidence of chronic diseases and growing approvals to novel parenteral nutrition components are projected to drive the global parenteral nutrition market during the forecast period.
Overview
Rise in prevalence of chronic diseases to Drive Market
Single dose amino acid solutions Segment to Dominate Market
North America to Dominate Global Market
Competitive Landscape
The global Parenteral Nutrition market has been segmented as follows:
By Type
By Region
A new study on the global parenteral nutrition market has been published by Vision Research Reports. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global parenteral nutrition market. The study offers valuable information about the global parenteral nutrition market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global parenteral nutrition market for the period 2020–2027, considering 2020 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global parenteral nutrition market during the forecast period.
An extensive analysis on business strategies of leading market players is also featured in study on the global parenteral nutrition market. This can help readers understand principal factors to foresee growth in the global parenteral nutrition market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global parenteral nutrition market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Questions Answered in Parenteral nutrition Market Study
- What are the key factors influencing the parenteral nutrition market in each region?
- What will be the CAGR of the global parenteral nutrition market between 2016 and 2027?
- What is the future scope and changing trends in technologies in the global parenteral nutrition market?
- Which factors will impede the growth of the global parenteral nutrition market during the forecast period?
- Which are the leading companies in the global parenteral nutrition market?
- Which region is set to expand at the fastest CAGR during the forecast period?
- What is the volume (Units) of different parenteral nutrition across all regions during the forecast period?
- Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Research Methodology
A unique research methodology has been utilized by Vision Research Reports to conduct a comprehensive research on the growth of the global parenteral nutrition market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global parenteral nutrition market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from parenteral nutrition industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making Vision Research Reports estimates on the future prospects of the global market more reliable and accurate.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Parenteral Nutrition Market, Nutrient Type
7.1. Parenteral Nutrition Market, Nutrient Type, 2020-2028
7.1.1. Carbohydrates
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Lipid Emulsion
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Single Dose Amino Acid Solution
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Trace Elements
7.1.4.1. Market Revenue and Forecast (2016-2028)
7.1.5. Vitamins & Minerals
7.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2. Europe
8.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3. APAC
8.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4. MEA
8.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5. Latin America
8.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
Chapter 9. Company Profiles
9.1. Baxter International Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Grifols International S.A.
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Actavis Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. B. Braun Melsungen AG
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Fresenius Kabi AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Hospira Inc.
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms